BioCentury
ARTICLE | Clinical News

Qa-Derp1 Immunodrug: Phase I

December 9, 2002 8:00 AM UTC

Interim results from an open-label, Swiss Phase I study in 24 volunteers showed Qa-Derp1 was well tolerated on initial immunization. Three subjects reported a mild local irritation and no systemic eff...